American College of Clinical Pharmacology Calls for Rethinking Sentinel Dosing in Early Clinical Trials The American College of Clinical Pharmacology released a position statement advocating for a more limited approach to sentinel dosing in clinical trials, emphasizing efficiency and safety.

American College of Clinical Pharmacology Calls for Rethinking Sentinel Dosing in Early Clinical Trials #USA #Clinical_Trials #Ashburn #ACCP #Sentinel_Dosing